New Zealand community mental healthcare provider experience in schizophrenia management with 3-monthly paliperidone palmitate.

CONCLUSIONS: From the clinician perspective, 3-monthly paliperidone palmitate offers patients the potential to remain adherent and improve social functioning.
PMID: 32586110 [PubMed - as supplied by publisher]

Source: Australasian Psychiatry - June 24, 2020 Category: Psychiatry Authors: Cassidy C, Miles W Tags: Australas Psychiatry Source Type: research